Medical Properties Trust (NYSE:MPW) Upgraded at BNP Paribas

Medical Properties Trust (NYSE:MPW - Get Free Report) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating in a report released on Wednesday,Briefing.com Automated Import reports. The brokerage currently has a $9.00 target price on the real estate investment trust's stock, up from their prior target price of $5.00. BNP Paribas' target price suggests a potential upside of 58.31% from the stock's current price.

Several other research analysts have also recently weighed in on the company. Royal Bank of Canada boosted their price objective on Medical Properties Trust from $4.00 to $5.00 and gave the stock a "sector perform" rating in a research report on Monday. Wells Fargo & Company boosted their price objective on Medical Properties Trust from $4.00 to $5.00 and gave the stock an "underweight" rating in a research report on Monday. Mizuho cut their price objective on Medical Properties Trust from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Thursday, December 5th. StockNews.com raised Medical Properties Trust from a "sell" rating to a "hold" rating in a research report on Monday, March 3rd. Finally, Truist Financial cut their price objective on Medical Properties Trust from $6.00 to $4.00 and set a "hold" rating on the stock in a research report on Thursday, December 19th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $5.64.

Remove Ads

Medical Properties Trust Stock Down 3.2 %

MPW stock opened at $5.69 on Wednesday. The stock's fifty day simple moving average is $4.72 and its two-hundred day simple moving average is $4.71. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69. Medical Properties Trust has a 1-year low of $3.51 and a 1-year high of $6.55. The stock has a market cap of $3.41 billion, a P/E ratio of -1.35, a P/E/G ratio of 1.01 and a beta of 1.32.

Insider Buying and Selling

In related news, CAO James Kevin Hanna sold 11,641 shares of the stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $3.72, for a total transaction of $43,304.52. Following the sale, the chief accounting officer now owns 366,913 shares of the company's stock, valued at approximately $1,364,916.36. This represents a 3.08 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.53% of the stock is currently owned by insiders.

Institutional Trading of Medical Properties Trust

Institutional investors have recently added to or reduced their stakes in the stock. Quadrature Capital Ltd purchased a new stake in Medical Properties Trust during the 3rd quarter worth about $927,000. JPMorgan Chase & Co. increased its stake in Medical Properties Trust by 21.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,704,785 shares of the real estate investment trust's stock worth $9,973,000 after acquiring an additional 303,628 shares during the last quarter. Versor Investments LP increased its stake in Medical Properties Trust by 192.3% in the 4th quarter. Versor Investments LP now owns 285,000 shares of the real estate investment trust's stock worth $1,126,000 after acquiring an additional 187,500 shares during the last quarter. Y Intercept Hong Kong Ltd increased its stake in Medical Properties Trust by 506.8% in the 4th quarter. Y Intercept Hong Kong Ltd now owns 63,207 shares of the real estate investment trust's stock worth $250,000 after acquiring an additional 52,790 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Medical Properties Trust by 353.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,525,714 shares of the real estate investment trust's stock worth $20,625,000 after acquiring an additional 2,748,245 shares during the last quarter. Hedge funds and other institutional investors own 71.79% of the company's stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.